{
    "title": "Former Takeda vaccine chief to lead new COVID antiviral venture Aerium",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10639513/Former-Takeda-vaccine-chief-lead-new-COVID-antiviral-venture-Aerium.html",
    "date": "2022-03-22",
    "keywords": [
        "venkayya",
        "company",
        "tuesday",
        "omicron",
        "vaccine",
        "takeda",
        "dengue",
        "research",
        "combination",
        "antibody",
        "virus",
        "march",
        "startup",
        "industry",
        "veteran",
        "rajeev",
        "coronavirus",
        "fastspreading",
        "ba2",
        "lab",
        "credibility",
        "venture",
        "co",
        "month",
        "president",
        "business",
        "zika",
        "moderna",
        "novavax",
        "japan",
        "aerium",
        "sum",
        "series",
        "financing",
        "capital",
        "boston",
        "development",
        "lausanne",
        "switzerland",
        "interview",
        "year",
        "time",
        "move",
        "use",
        "infection",
        "response",
        "difference",
        "population",
        "covid",
        "companys",
        "platform",
        "laboratory",
        "immunity",
        "delta",
        "ba11",
        "preprint",
        "server",
        "biorxiv",
        "paper",
        "publication",
        "journal",
        "infusion",
        "injection",
        "office",
        "threetosix",
        "julie",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}